ICS 2015 Scientific Podium Short Oral Session S20 - New Research in Neuromodulation

Speakers
	Thursday 8th October 2015
	11:00 - 12:30
	210AE
E Enrico Finazzi Agrò ICS Chair G Genevieve Nadeau ICS Chair
Learning Objectives
To examine novel research findings in the field of New Research in Neuromodulation. To discuss methodological challenges for conducting research in the field of New Research in Neuromodulation. To discern the internal and external generalizability of these research results in order to implement changes in research methods or clinical practice within the participant's own setting.

11:00

#255 Real-World Effectiveness of Percutaneous Tibial Nerve Stimulation

Presenter: Yahir Santiago-Lastra

Santiago-Lastra Y¹, Oldendorf A¹, Stoffel J¹, Clemens J Q¹, Cameron A P¹
1. University of Michigan
Neuromodulation, Retrospective Study, Urgency Urinary Incontinence, Overactive Bladder, Urgency/Frequency

11:07

#256 Randomized trial of tibial nerve stimulation (TNS) in motor and sensory thresholds for treating overactive bladder (OAB) in older women – pilot study

Presenter: Aline Teixeira Alves

Alves A T¹, Jácomo R H², Bontempo A P S¹, Gomide L B¹, Botelho T L¹, Rett M T³, Garcia P A¹
1. UnB - University of Brasilia, 2. HUB - University Hospital of Brasilia, 3. Federal University of Sergipe - UFS
Conservative Treatment, Gerontology, Physiotherapy, Overactive Bladder, Neuromodulation

11:15

#257 Home based therapeutic application of non-invasive posterior tibial nerve stimulation in the treatment of overactive bladder symptoms: a pilot clinical trial

Presenter: Martin Slovak

Slovak M¹, Hillary C², Osman N², Chapple C², Barker A³
1. Devices For Dignity, Sheffield Teaching Hospitals NHS Foundation Trust, 2. Department of Urology, Sheffield Teaching Hospitals NHS Foundation Trust, 3. Department of Medical Physics & Clinical Engineering, Sheffield Teaching Hospitals NHS Foundation Trust
Urgency/Frequency, Clinical Trial, Overactive Bladder, Neuromodulation

11:22

#258 Low-frequency transcutaneous electrical stimulation of foot ameliorates intractable OAB symptoms

Presenter: Yosuke Matsuta

Matsuta Y¹, Yokoi S¹, Hashimoto N², Aoki Y¹, Akino H¹, Yokoyama O¹
1. Department of Urology, Faculty of Medical Sciences, University of Fukui, 2. Department of Clinical Laboratory, Faculty of Medical Sciences, University of Fukui
Neuromodulation, Overactive Bladder, Conservative Treatment, Voiding Diary, Questionnaire

11:30

#259 ELECTRICAL STIMULATION OF SOMATIC AFFERENT NERVES IN THE FOOT IMPROVES OVERACTIVE BLADDER SYMPTOMS

Presenter: Christopher Chermansky

Chermansky C¹, Chen M¹, Shen B¹, Roppolo J², de Groat W², Erickson J¹, Tai C¹
1. Dept of Urology - University of Pittsburgh, 2. Dept of Pharmacology and Chemical Biology - University of Pittsburgh
Neuromodulation, Urgency Urinary Incontinence, Urgency/Frequency, Overactive Bladder

11:37

#260 Saphenous Nerve Stimulation: A Novel Bladder-Inhibitory Reflex Pathway Evoked in Anesthetized Rats

Presenter: Zainab Moazzam

Moazzam Z¹, Yoo P¹
1. University of Toronto
Overactive Bladder, Incontinence, Neuromodulation, Urgency/Frequency

11:45

#261 CT-Guided Sacral Neuromodulation S3 - A New Targeted Approach After Initial Treatment Failure: The First 10 Patients

Presenter: Sophina Trubel

Trubel S¹, Meissnitzer T¹, Meissnitzer M¹, Janetschek G¹, Zimmermann R P¹
1. Paracelsus Medical University Salzburg
Neuromodulation, Detrusor Hypocontractility, Clinical Trial, Detrusor Overactivity

11:52

#262 The impact of duration of complaints on successful sacral neuromodulation outcome

Presenter: Philip Van Kerrebroeck

Drossaerts J¹, Arnts J², van den Anker C², van Koeveringe G¹, Van Kerrebroeck P¹
1. Maastricht University Medical Centre, 2. Maastricht University
Underactive Bladder, Overactive Bladder, Neuromodulation, Urgency Urinary Incontinence

12:00

#263 Does prior treatment with intravesical botulinum toxin A affect the outcome of sacral neuromodulation evaluation in patients with refractory detrusor overactivity?

Presenter: Helen Morton

Morton H¹, Harding C¹
1. Freeman Hospital, Newcastle upon Tyne, UK
Detrusor Overactivity, Neuromodulation, Urgency/Frequency, Incontinence

12:07

#264 Detailed Analysis of Adverse Events and Surgical Intervention in a Large Prospective Trial of Sacral Neuromodulation Therapy For Overactive Bladder Patients

Presenter: Karen Noblett

Noblett K¹, Benson K², Kreder K³
1. University of California, Riverside, 2. Sanford Health, 3. University of Iowa
Clinical Trial, Neuromodulation, Overactive Bladder, Infection, other

12:15

#265 The cost-utility of Sacral Neuromodulation versus Botulinum Toxin A for the treatment of refractory idiopathic overactive bladder (with urgency urinary incontinence) in Sweden

Presenter: Elisabeth Reimer

Borisenko O¹, Reimer E², Colpan Z¹, Petkovski A¹
1. Synergus AB, 2. Medtronic
Incontinence, Neuromodulation, Mathematical or statistical modelling, Overactive Bladder, Quality of Life (QoL)

12:22

#266 Long term cost effectiveness of botulinum toxin A and sacral neuromodulation for patients with refractory overactive bladder.

Presenter: Deepak Harry

Harry D¹, Roberts S², Parkin D², Malde S¹, Al-Kaisy A¹, Sahai A¹
1. Guy's Hospital, 2. King's College London
Neuromodulation, Detrusor Overactivity, Overactive Bladder, Mathematical or statistical modelling

Content Visitors (staff only)

New Research in Neuromodulation

Scientific Podium Short Oral Session S20

Session Schedule

Comments

Chat